Comparative analysis of five-year clinical outcomes of autologous hematopoietic stem cell transplantation and alemtuzumab in multiple sclerosis patients.


Manazoğlu H. C., İşkan G., Gündüz T., Emekli A. S., Akman G., Altunrende B., ...More

Multiple sclerosis and related disorders, vol.100, pp.106542, 2025 (SCI-Expanded, Scopus) identifier identifier identifier